Skip to main content
Giulio Superti-Furga, Michael Häupl, Alexander V. d. Bellen and Anita Ender - Foto: Klaus Pichler

CeMM-visit of President Alexander Van der Bellen and Mayor Michael Häupl

CeMM had the pleasure to host the Federal President of Austria, Alexander Van der Bellen, and the Mayor of the City of Vienna, Michael Häupl on October 3, 2017. The guests came to our institute on the occasion of CeMM´s 10th anniversary, which we celebrated in September, and to inaugurate our PhD Gallery.

Welcomed by CeMM Directors Giulio Superti-Furga and Anita Ender and cheered by the entire staff of CeMM, the guests were accompanied to the CeMM Time Capsule, the first stop of their visit. After receiving one of the notebooks with the invitation to write down their thoughts and ideas, President Van der Bellen and Mayor Häupl met PhD…

Read more
Foto: Hans Leitner

CeMM Outing 2017 - Göttweig Abby and Schallaburg

On September 29, 2017, the CeMM members went on the annual outing of the institute, to start the academic year with a community experience, to strengthen the relationships with colleagues, and to broaden our horizon. This year, we visited Göttweig Abby and the Schallaburg, both spectacular historic sites in a picturesque landscape.

On perfect weather, the trip started with a visit of Göttweig Abby, also known as “Lower Austria´s Montecassino” for its beautiful location on top of a hill. The Benedictine monastery, founded in the 11th century, is full of valuable collections of religious engravings, coins, antiquities and musical manuscripts,…

Read more
Foto: belle & sass

Artificial Hearts Exhibition & Brain Lounge Discussion

On September 28, 2017, Christiane Druml, Director of the Josephinum of the Medical University of Vienna, Curator Moritz Stipsicz, and CeMM Director Giulio Superti-Furga invited to a journey to the very heart of the interface of art and science. On the occasion of the exhibition “Artificial Hearts – The Bridge to Survival” in the Josephinum, a motley audience of artists, physicians, scientists and students visited the astonishing collection of historic medical exhibits and contemporary art pieces and installations, followed by a lively discussion round in CeMM´s Brain Lounge.

Vienna has played a pioneering role in the development of the…

Read more
Jo Bury, Director of the VIB and Chair of EU-LIFE             Foto: Klaus Pichler

EU-LIFE’s Position paper on FP9: Towards better research value in Europe

CeMM is member of EU-LIFE (www.eu-life.eu). EU-LIFE is a European alliance of research centers of excellence in life sciences, whose mission is to support and strengthen European research excellence. Representing over 7,200 scientists and staff distributed in more than 500 research groups across Europe, EU-LIFE is a strong representative of the scientific community throughout Europe.

In a position paper we announce our key priorities for the next Framework Program for Research and Development (FP9) that will run from 2021 to 2027, which can be summarized as follows: 

• To double the investment by the European Commission to 150 billion euro…

Read more
Foto: Klaus Pichler

10th Anniversary of CeMM

Blistered dancing feet, tissues wet with tears of joy and the taste of cake still on our lips: the 10th anniversary celebration on September 12, 2017 at the Aula der Wissenschaften was CeMM´s biggest, most spectacular and memorable event we had since the opening of our research building. 

We thank everybody who celebrated with us and who contributed to the success of CeMM over the past years! It is your support and friendship that motivates us to do the best possible research. 

Exhausted but happy, we summarize CeMM´s decennial jubilee as follows: Moderator Annie Kay wonderfully guided the audience through a mixture of overwhelming light…

Read more

Allcyte - a new spin-off company from CeMM provides diagnostics and drug discovery for blood cancers

CeMM today officially announces the start of operation of a new spin-off company, Allcyte, founded by CeMM Director Giulio Superti-Furga, Berend Snijder, now Professor at the ETH Zurich, Gregory Vladimer, and Nikolaus Krall. The team met while Snijder, Vladimer, Krall were postdoctoral fellows in the research group of Giulio Superti-Furga. Allcyte supports pre-clinical drug development and clinical decision making services by helping physicians find the right drug for the right patients, and pharmaceutical companies identify the most promising indications for their drugs and drug candidates. In the era of big-data medicine, Allcyte is built…

Read more
The lead authors of the study: Quanah Hudson, Daniel Andergassen, Denise Barlow and Florian Pauler (f.l.t.r.)

Gene variant activity is surprisingly dynamic during development

Every tissue has its own pattern of active alleles (the gene variants inherited from the mother or father),. For the first time, scientists were able to show that the differential allele activity is regulated by tissue-specific, regulatory DNA elements known as enhancers – a process that could also be involved in many diseases. The results of the former CeMM group of Denise Barlow were published in the high-profile open access journal eLife.

Every gene in (almost) every cell of the body is present in two variants – so called alleles: one is deriving from the mother, the other one from the father. In most cases both alleles are active and…

Read more
Co-first author Rico Chandra Ardy (left) and senior author Kaan Boztug (right)

Newly discovered rare disease helps understand the complexity of bowel homeostasis

A single-gene mutation may cause a severe bowel disease in children. This could be shown in a recent study by an international research team led by Kaan Boztug at CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD) together with Michael Lenardo, National Institute of Health (NIH), Bethesda.

The newly discovered alterations lead to total loss of a protein called CD55, causing life-threatening bowel inflammation, chronic diarrhea and vascular thrombosis. The researchers unraveled the underlying molecular mechanisms and discovered…

Read more

Order of Merit of the Italian Republic awarded to Giulio Superti-Furga

On June 7th, 2017 Giulio Superti-Furga was awarded the title of Commendatore (Commander) dell'Ordine al Merito della Repubblica Italiana (Order of Merit of the Italian Republic) by HE Giorgio Marrapodi, Ambassador of Italy.

The order was given by decree of the President of the Italian Republic Sergio Mattarella, who had visited CeMM together with Austria´s former President Heinz Fischer during his first official states visit to Austria in 2015. The Order of Merit is the highest-ranking honor system of the Italian Republic and is awarded for "merit acquired by the nation" in the fields of literature, the arts, economy, public service, and…

Read more
(c) Nature Chemical Biology  / Stefan Kubicek

A CLOUD of Possibilities: Finding New Therapies by Combining Drugs

The CeMM Library of Unique Drugs (CLOUD) is the first condensed set of FDA-approved drugs representing the entire target and chemical space of all clinical compounds. Its potential was shown in a combinatorial high throughput screen at the CeMM chemical screening platform and published in Nature Chemical Biology: A pair of hitherto unrelated drugs proved to be highly effective against multiple prostate cancer cell lines. 

(Vienna, May 22, 2017) The synergy of two combined pharmaceuticals assessed in an experimental setting can reveal completely new therapeutic options. Nevertheless, finding a novel combination of drugs for a given disease…

Read more